EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access

Noncoding RNAs as Prognostic Biomarkers After Myocardial Infarction: A Scoping Review

Łukasz Wi Niowski iD, Maciej Biskupski iD, Robert Błaszczyk iD, Bartosz Kondracki iD, Jan Siwiec iD, Radosław Mlak iD, Andrzej Głowniak

Journal of the American Heart Association · 01.09.2026 · 15 (17)

DOI: 10.1161/jaha.126.050885 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Journal of the American Heart Association, erschienen am 01.09.2026. Verfasst von Łukasz Wi Niowski und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Medical University of Lublin Lublin Poland. Hauptthemen laut MEDLINE: Myocardial Infarction, RNA, Untranslated. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prognosis after myocardial infarction (MI) remains heterogeneous despite contemporary reperfusion and secondary prevention, and biomarkers that capture post‐MI recovery, treatment response, and long‐term risk are still limited. Noncoding RNAs have therefore attracted interest as biomarkers of post‐MI risk and recovery.

Methods

We conducted a scoping review of human studies evaluating circulating or blood‐derived noncoding RNAs, including microRNAs, long noncoding RNAs, circular RNAs, and tRNA‐derived small RNAs/tRNA‐derived fragments, measured after MI in relation to prognostic phenotypes, clinical outcomes, or treatment‐response end points.

Results

Forty‐six studies were included. Most were observational, focused on plasma or serum microRNAs, and used quantitative reverse transcription–polymerase chain reaction, but sample size, sampling phase, normalization strategy, end point definition, follow‐up duration, and validation approaches varied substantially. Reported associations clustered around reperfusion‐related injury/no reflow or microvascular obstruction, left ventricular remodeling or dysfunction, clinical events, including major adverse cardiovascular events and mortality, and a smaller group of treatment‐response phenotypes. Directional signals included miR‐30e, miR‐660‐5p, TUG1 , and MALAT1 for no reflow; LIPCAR , MICRA , miR‐320a, miR‐1254, and miR‐22‐3p for remodeling or ventricular recovery; miR‐145, miR‐223‐3p, miR‐126‐3p/miR‐223‐3p, HCG11 /miR‐532‐3p, and exosomal miR‐186‐5p dynamics for clinical events; and BANCR or selected tRNA‐derived small RNAs/tRNA‐derived fragments for treatment‐response heterogeneity. The most plausible candidates were phenotype specific rather than universal, with event‐related microRNA models, imaging‐linked remodeling markers, and no‐reflow/microvascular obstruction–associated candidates appearing more mature than isolated injury‐linked diagnostic microRNAs or single‐study treatment‐response signals.

Conclusions

Overall, noncoding RNAs show promise as adjunctive post‐MI biomarkers, but clinical translation requires phase‐aligned sampling, assay standardization, external validation, and direct testing of incremental value beyond established clinical, imaging, and protein‐biomarker models.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionRNA, UntranslatedHumansPrognosisBiomarkersMicroRNAs

Stichwörter der Autor:innen

biomarkersmicroRNAsmyocardial infarctionnoncoding RNAprognosis

Substanzen

BiomarkersRNA, UntranslatedMicroRNAs

Autor:innen und Institutionen

  • Department of Cardiology Medical University of Lublin Lublin Poland.
  • Department of Plastic, Reconstructive Surgery and Microsurgery Medical University of Lublin Lublin Poland.
  • Department of Pneumonology, Oncology and Allergology Medical University of Lublin Lublin Poland.
  • Department of Laboratory Diagnostics Medical University of Lublin Lublin Poland.

ORCID-Profile: Łukasz Wi Niowski, Maciej Biskupski, Robert Błaszczyk, Bartosz Kondracki, Jan Siwiec, Radosław Mlak

Zitieren

APA

Wi Niowski, Ł., Biskupski, M., Błaszczyk, R., Kondracki, B., Siwiec, J., Mlak, R., & Głowniak, A. (2026). Noncoding RNAs as Prognostic Biomarkers After Myocardial Infarction: A Scoping Review. Journal of the American Heart Association, 15(17). https://doi.org/10.1161/jaha.126.050885

Vancouver

Wi Niowski Ł, Biskupski M, Błaszczyk R, Kondracki B, Siwiec J, Mlak R, et al. Noncoding RNAs as Prognostic Biomarkers After Myocardial Infarction: A Scoping Review. Journal of the American Heart Association. 2026;15(17). doi:10.1161/jaha.126.050885

BibTeX
@article{WiNiowski2026,
  author = {Wi Niowski, Łukasz and Biskupski, Maciej and Błaszczyk, Robert and Kondracki, Bartosz and Siwiec, Jan and Mlak, Radosław and Głowniak, Andrzej},
  title = {Noncoding RNAs as Prognostic Biomarkers After Myocardial Infarction: A Scoping Review},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {17},
  doi = {10.1161/jaha.126.050885}
}
Kostenlos starten →